Defining myeloid-derived suppressor cells.

Akkari, Leila; Amit, Ido; Bronte, Vincenzo; Fridlender, Zvi G; Gabrilovich, Dmitry I; Ginhoux, Florent; Hedrick, Catherine C; Ostrand-Rosenberg, Suzanne

Akkari, Leila; Amit, Ido; Bronte, Vincenzo; Fridlender, Zvi G; Gabrilovich, Dmitry I; Ginhoux, Florent; Hedrick, Catherine C; Ostrand-Rosenberg, Suzanne.

Afiliação

Akkari L; Division of Tumour Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands. l.akkari@nki.nl.
Amit I; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. ido.amit@weizmann.ac.il.
Bronte V; Instituto Oncologico Veneto IOV-IRCCS, Padua, Italy. vincenzo.bronte@iov.veneto.it.
Fridlender ZG; Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Fridlender@hadassah.org.il.
Gabrilovich DI; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Fridlender@hadassah.org.il.
Ginhoux F; ICC, Early Oncology, AstraZeneca, Gaithersburg, MD, USA. dmitry.gabrilovich@astrazeneca.com.
Hedrick CC; Gustave Roussy Cancer Campus, Villejuif, France. florent.ginhoux@gustaveroussy.fr.
Ostrand-Rosenberg S; Paris-Saclay University, Paris, France. florent.ginhoux@gustaveroussy.fr.

Nat Rev Immunol ; 2024 Jul 05.

Article em En | MEDLINE | ID: mdl-38969773

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Rev Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google